On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Provides Viable Renewable Energy Solutions That Reduce Methane Emissions

  • Methane is believed to cause climate change by trapping 86 times more heat in the atmosphere than carbon dioxide
  • EVGIF advances RNG technology that negates the effects of methane while combatting carbon dioxide production caused by burning natural gas
  • The RNG production process produces biogas that can be refined and purified to create pipeline-quality RNG, which can be injected into current networks
  • EverGen aims to create an RNG network comprising 20+ facilities across Canada within five years

Methane is released while producing and transporting coal, natural gas, and oil. As a result, climate justice activists believe methane causes climate change by trapping 86 times more heat in the atmosphere than carbon dioxide alone (https://ibn.fm/M80Wk). Fortunately, EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), a Canadian renewable energy company, offers a solution through renewable natural gas (“RNG”) technology that negates the effects of methane while combatting carbon dioxide production associated with burning natural gas.

Experts from the World Economic Forum believe that methane emissions must drop to reach climate goals (https://ibn.fm/bErq9). According to the organization, methane emissions caused roughly 30% of global temperature increases since industrialization, and the problem is getting worse as emissions reach record levels.

RNG technology provides a solution that is more than just carbon-neutral – it’s carbon negative due to its ability to remove methane that otherwise would be produced when organic matter decomposes. The RNG production process leverages a process called anaerobic digestion that uses microorganisms to break down organic materials such as sewage sludge, organic waste, and animal manure in an enclosed, oxygen-free container (https://ibn.fm/FZe1A). The process then creates two primary products: digestate – a by-product that can be used as crop fertilizer, and biogas – a renewable source of methane gas.

Biogas can be refined and purified to create RNG – a pipeline-quality gas that can be injected into existing networks. EverGen aims to develop such a network comprising 20+ facilities within five years by acquiring, managing, and developing RNG and waste-to-energy projects nationwide.

Current projects in the company’s portfolio include Fraser Valley Biogas, Sea to Sky Soils, and Net Zero Waste Abbotsford in British Columbia, and a 67% stake in Alberta-based GrowTEC. Across the country in Ontario, EverGen has a 50% stake in Project Radius – a portfolio of three large, on-farm, and late-stage development projects that can potentially produce up to 1.7 million GJ of RNG annually.

The company is based in British Columbia – a province that actively takes action to reduce overall greenhouse gas emissions by supporting projects that displace equivalent volumes of traditional natural gas with carbon-neutral RNG. “The more RNG we have, the less conventional natural gas we need,” said Jenelle De La Cour, a manager of renewable gas accounts with FortisBC (https://ibn.fm/cr9bd). “Every RNG project is a win for climate action.”

EverGen leads RNG adoption in Canada with a portfolio of carbon negative RNG projects across the country. The company is committed to unlocking the power of carbon negative RNG to combat climate change, improve sustainability, and help reach worldwide emission targets.

For more information, visit the company’s website at www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

From Our Blog

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

July 23, 2024

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have […]

Rotate your device 90° to view site.